Epidemiological aspects of poisoning Infectious-toxic bacteria of botulism on food poisoning in Iran; A review study

Published on Apr 1, 2022in European Journal of Vascular and Endovascular Surgery7.069
· DOI :10.21608/EJVS.2021.86225.1253
Halleh Mirbehresi , Mohadeseh Pirhadi2
Estimated H-index: 2
+ 1 AuthorsAlireza Esmaeili (Tehran University of Medical Sciences)
#1Mariarosaria Valente (University of Udine)H-Index: 23
Chronic pain syndromes present a subversion of both functional and structural nociceptive networks. We used transcranial magnetic stimulation (TMS) to evaluate changes in cortical excitability and plasticity in patients with chronic migraine (CM) treated with botulinum neurotoxin type A (BoNT/A). We enrolled 11 patients with episodic migraine (EM) and 11 affected by CM. Baseline characteristics for both groups were recorded using single- and paired-pulse TMS protocols. The same TMS protocol was ...
#1Bettina Pfausler (Innsbruck Medical University)H-Index: 33
#2Verena RassH-Index: 8
Last. Ronny BeerH-Index: 29
view all 4 authors...
PURPOSE OF REVIEW The incidence rates of the toxin-related infectious diseases, tetanus, diphtheria and botulism declined dramatically over the past decades mainly because of the implementation of immunization programs also in low-and-middle-income countries (LAMICs) and by improving hygiene conditions. But still, single cases occur, and they need fastest possible recognition and management. RECENT FINDINGS Over the past 20 years, the incidence of neonatal tetanus has declined by more than 90%. ...
Parkinson's disease is the most common age-related motoric neurodegenerative disease. In addition to the cardinal motor symptoms of tremor, rigidity, bradykinesia, and postural instability, there are numerous non-motor symptoms as well. Among the non-motor symptoms, autonomic nervous system dysfunction is common. Autonomic symptoms associated with Parkinson's disease include sialorrhea, hyperhidrosis, gastrointestinal dysfunction, and urinary dysfunction. Botulinum neurotoxin has been shown to p...
#1A. M. CostaH-Index: 4
#2João Manuel SilvaH-Index: 1
Last. Céu EvangelistaH-Index: 1
view all 6 authors...
#1Jara Schulze (MHH: Hannover Medical School)H-Index: 2
#2Insa Neumann (Semmelweis University)H-Index: 3
Last. Tillmann H.C. Kruger (MHH: Hannover Medical School)H-Index: 28
view all 7 authors...
Abstract Botulinum toxin (BTX) treatment of glabellar frown lines is one of the most common procedures in aesthetic medicine. In addition to its cosmetic effect, the neurotoxin has been shown to have a positive influence on mood and affect. Several randomized clinical trials (RCTs) have examined the effect of botulinum toxin on the treatment of depression. Combining the results of the five RCTs in a random effects meta-analysis revealed that patients treated with BTX showed a more intense improv...
#1Alberto Friziero (UNIPD: University of Padua)H-Index: 5
#2Cosimo Sperti (UNIPD: University of Padua)H-Index: 36
Last. Stefano Merigliano (UNIPD: University of Padua)H-Index: 23
view all 10 authors...
BACKGROUND Small bowel obstruction is one of the leading reasons for accessing to the Emergency Department. Food poisoning from Clostridium botulinum has emerged as a very rare potential cause of small bowel obstruction. The relevance of this case report regards the subtle onset of pathognomonic neurological symptoms, which can delay diagnosis and subsequent life-saving treatment. CASE PRESENTATION A 24-year-old man came to our Emergency Department complaining of abdominal pain, fever and sporad...
#1Charenya Anandan (BCM: Baylor College of Medicine)H-Index: 1
#2Joseph Jankovic (BCM: Baylor College of Medicine)H-Index: 176
Since its initial approval in 1989 by the US Food and Drug Administration for the treatment of blepharospasm and other facial spasms, botulinum toxin (BoNT) has evolved into a therapeutic modality for a variety of neurological and non-neurological disorders. With respect to neurologic movement disorders, BoNT has been reported to be effective for the treatment of dystonia, bruxism, tremors, tics, myoclonus, restless legs syndrome, tardive dyskinesia, and a variety of symptoms associated with Par...
#1Patrick M. McNutt (Wake Forest Institute for Regenerative Medicine)H-Index: 16
Last. Konstantin Ichtchenko (NYU: New York University)H-Index: 10
view all 15 authors...
Botulism is caused by a potent neurotoxin that blocks neuromuscular transmission, resulting in death by asphyxiation. Currently, the therapeutic options are limited and there is no antidote. Here, we harness the structural and trafficking properties of an atoxic derivative of botulinum neurotoxin (BoNT) to transport a function-blocking single-domain antibody into the neuronal cytosol where it can inhibit BoNT serotype A (BoNT/A1) molecular toxicity. Post-symptomatic treatment relieved toxic sign...
#1Syahla Nisaa Amalia (Gunma University)H-Index: 2
#2Akihiko Uchiyama (Gunma University)H-Index: 21
Last. Sei-ichiro Motegi (Gunma University)H-Index: 19
view all 13 authors...
Abstract Background Psoriasis is a multifactorial disease arises from a complex interaction of genetics, immune system, and environmental aspects. IL-23/Th17 immune axis has been considered as a primary modulator in psoriasis. In addition, several findings imply that nervous system may take a part in the pathogenesis of psoriasis, suggesting that nervous system, through its neuropeptide, may interact with immune system and lead to the formation of psoriasis. Objective We aimed to ascertain the r...
#1Anna P. Andreou (HealthPartners)H-Index: 23
#2Charlotte Leese (University of Sheffield)H-Index: 9
Last. Bazbek Davletov (University of Sheffield)H-Index: 50
view all 16 authors...
With a prevalence of 15%, migraine is the most common neurological disorder and among the most disabling diseases, taking into account years lived with disability. Current oral medications for migraine show variable effects and are frequently associated with intolerable side effects, leading to the dissatisfaction of both patients and doctors. Injectable therapeutics, which include calcitonin gene–related peptide–targeting monoclonal antibodies and botulinum neurotoxin A (BoNT/A), provide a new ...
Cited By0
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.